HOME
ORGANIZING COMMITTEE
GENERAL INFORMATION
INVITED SPEAKERS AND CHAIRMEN
PRELIMINARY PROGRAM
POSTER PRESENTATION
REGISTRATION FORM
POSTER PRESENTATION
New topical hemostatic sponge Thrombocol.
Belozerskaya G., Makarov V.A., Aboyanz R.K., Istranov L.P., Malychina L.S.High factor XIII activity is new type of hematogenic thrombophilia.
Berkovski A., Vasiliev S., Sergeeva E., Orel E.The role of LMWH in pregnant women with antiphospholipid syndrome.
Boda Z., Laszlo P., Pfliegler G., Schlammadinger A., Razso K., Posan E.Thromboembolism of pulmonary artery. What to do?
Bokarev I., Popova.LComparison of efficiency and consequences of various methods thrombolysis at the patients with myocardial infarction.
Gnezdilova N., Khlevchuk T., Bokarev I.Stable isotope labelling of human platelets for determination of kinetics in children and pregnants.
Granegger S., Hann S., Stingeder G., Sinzinger H.Factor Xa inhibition by naturally occurring humic acids and synthetic humic acid-like polymers.
Klöcking H.P., Mahr N., Klöcking R., Heise K.-H.Effects of eptifibatide and anticoagulants on thrombin generation and platelet aggregation at high and low coagulant challenge in vitro.
Koestenberger M., Gallistl S., Cvirn G., Petritsch M., Muntean W.The pleiotropic effects of unfractionary heparin.
Kondashevskaya M. V., Nikolskaya K. A., Kostenkova V. N.Antihypoxic effect of heparin in altichamber hypoxia.
Kondashevskaya M. V.The complications of long-term treatment with low-molecular heparin during pregnancy.
Krcová V., Procházka M., Krc I., Slavík L., Prásilová J.Adaptation of protein S activity determination (STAGO) on COAG-A-MATE MTX. Some fals negative results.
László P.The effect of the heparin-like plant component on the fibrinolytic activity of blood plasma.
Lyapin G.YU, Smolina T.YU, Uspenskaya M.S.Influence of high negative charged polymers on the blood coagulation factor VIIa activity.
Mahr, N., Klöcking, H.-P., Möller, S.Effect of I125 on oxidation behaviour of lipoprotein subpopulations.
Majtenyi S., Fleger M., Resch U., Sinzinger H.Importance of genetic and haemostaseologic examination in stroke.
Nagy A., Nagy F., Dávid M., Bölcskei K., Meng B., Losonczy H.The determination of activity of glycoprotein IIb/IIIa and von Willebrand's factor complex for the control of antithrombosis therapy with the inhibitors of glycoprotein IIb/IIIa.
Nesova T., Kiseloyva Z., Bokarev I.Determination of the functional activities of glycoprotein IIb/IIIa and von Willebrand's factor complex at acute coronary syndrome.
Nesova T., Kiselyova Z., Bokarev I.Diagnostic kits with original chromogenic substrates for plasminogen and antithrombin III determine.
Nevedrova O.E., Makarov V.A., Momot A.P., Mamaev A.N., Barkagan Z.S., Voyushina T.L.Thrombophilia markers and venous thromboembolism.
Obradovic D., Mitic G.Serum thrombopoietin (TPO) levels in patients with thrombocytosis.
Podolak -Dawidziak M., Werynska B., Ramlau R., Prajs I., Jankowska R., Kuliczkowski K.Psychostimulation improves mental activity but disturb processes haemostasis and fibrinolysis.
Podorolskaya L., Nikolskaya K., Kostenkova V., Serebryakova T., Andreenko G.Estimation of the personal risk of the venous thromboembolism.
Popova L, Bokarev I.Dose dependant influence of thymoptin (preparation from thymus ) on clinical course and processes of haemostasis and fibrinolysis in rats with experimental nephritis.
Raevskaya A., Podorolskaya L., Serebryakova T., Andreenko G.Antioxidant status in thyroid malfunction.
Resch U., Hesel G., Tatzber F., Sinzinger H.Permeability of normal blood clot.
Savushkin AL.Permeability method in fibrinolysis study.
Savushkin AL.Management of gastrointestinal bleeding in type 2B von Willebrand's disease. A case report.
Schlammadinger A., Altorjay I., Udvardy M., Boda Z.Factor V Leiden and other thrombotic risk factors in CHD and myocardial infarction.
Schröder W., Grimm R., Schuster G., Brüser M., Wulff K., Rieger M., Völzke H., John U., Herrmann FH.Fibrinolytic activity is decreased during a course of hemodialysis in patients treated with erythropoietin.
Stasko J., Galajda P., Ivanková J., Peterková M., Sutarík L., Makovický P., Hudecek J., Mokán M., Kubisz P.Haemorheologic and microcirculatory modifications in heart failure.
Turchetti V., Bellini M.A., Boschi L., Pallassini A., Richichi M.G., Postorino G., Guerrini M., Forconi S.Antidiabetogenic and antithrombotic effects of the insulin-heparin complex.
Uljanov A.M., Lyapina L.A., Pastarova V.E.The influence of novel synthetic dophamine-amides of PUFA on human platelet aggregation in vitro.
Vasilieva T.M., Petrukhina G.N., Makarov V.A., Bezuglov V.V., Gretskaya N.MFV Leiden and Val34Leu Polymorphism in the Factor XIII Gene - Analysis and Association with Deep Vein Thrombosis.
Vogel G., Lauschus R., Schuster G., Schroeder W., John U., Weber E., Herr F.H.Mutation analysis of FVII deficiency in Slovakia.
Wulff K., Batorova A., Herrmann F.H.
ORGANIZING AGENCY
CONSULTA UMBRIA
Piazza Italia, 9
06121 Perugia, ITALY
Tel +39 075 5720608
Fax +39 075 5721913
congressi@consultaumbria.com